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Abstract 
Synthesis of(Z)-4-(3-carboxyacrylamido)-2-hydroxybenzoic acid ligand from acetic anhydride and  p- amino 
salicylic acid was complex with Co(II),Ni(II) and Cr(III),the complexes have been characterized by 
spectral(FTIR,Uv-Vis)and electrochemical method using conductmetric ,the resulting nanoparticles were 
characterized by X-ray diffraction (XRD) and biological activity  . 
 
Introduction  
Aminosalicylic acid was introduced to clinical use in 1944. It was the second antibiotic found to be effective in 
the treatment of tuberculosis, after streptomycin. PAS formed part of the standard treatment for tuberculosis prior 
to the introduction of rifampicin and pyrazinamide.[4] 
Its potency is less than that of the current five first-line drugs (isoniazid, rifampicin, ethambutol, 
pyrazinamide, and streptomycin) for treating tuberculosis and its cost is higher, but it is still useful in the treatment 
of multidrug-resistant tuberculosis.[1] PAS is always used in combination with other anti-TB drugs. 
The dose when treating tuberculosis is 150 mg/kg/day divided into two to four daily doses; the usual adult 
dose is therefore approximately 2 to 4 grams four times a day. It is sold in the US as "Paser" by Jacobus 
Pharmaceutical, which comes in the form of 4 g packets of delayed-release granules. The drug should be taken 
with acid food or drink (orange, apple or tomato juice).[5] PAS was once available in a combination formula with 
isoniazid called Pasinah[6] or Pycamisan 33.[7] 
The European Medicines Agency (EMA) has recommended granting a marketing authorization for PAS 
in multidrug-resistant tuberculosis in adults and children when other treatments cannot "be devised for reasons of 
resistance or tolerability 8,9] 
Gastrointestinal side-effects (nausea, vomiting, diarrhoea) are common; the delayed-release formulation 
is meant to help overcome this problem.[10] It is also a cause of drug-induced hepatitis. Patients with glucose-6-
phosphate dehydrogenase deficiency should avoid taking aminosalicylic acid as it causes haemolysis.[11] Thyroid 
goitre is also a side-effect because aminosalicylic acid inhibits the synthesis of thyroid hormones.[12] 
Drug interactions include elevated phenytoin levels. When taken with rifampicin, the levels of rifampicin 
in the blood fall by about half.[9] 
 
Matrial 
para-aminosalicylic acid manufacture by Fluka ,dry ethyl ether and acetic anhydride manufacture by BDH,nickel 
chloride manufacture by Alpha,coblet chloride manufacture by Marck,cyclohexane ,chromium chloride and 
sodium acetate  manufacture by RDH. 
 
Method 
Preparation of ligand 
In a 1L two necked round bottom flask provided with a reflux condenser and dropping funnel ,30 g (0.3 mole)and 
382 ml of dry  ethyl ether were placed stirring was started by using a magnetic was dissolved a solution of 0.3 
mole of compound in 30 ml of dry ethyl ether the resulting thick suspension was stirred at room temperature for 
1hr and then cooled to 15-20oC in an ice bath, the product was obtained by suction filtration  in the form of fine 
yellow powder with reaction bellow 
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Preparation of complexes 
The aqueous solution of 0.1 mol of metal salts of(CoCl2 ,CrCl3 and NiCl2) was added with constant stirring to an 
ethanol solution of 0.2mol of(Z)-4-(3-carboxyacrylamido)-2-hydroxybenzoic acid.  Reaction mixture was stirred 
at room temperature for 5 hours. The colored precipitate was obtained .The precipitate was filtered and washed 
with water and then with methanol and dried over calcium chloride in a desiccator .All the complexes were 
prepared in 1:2 ratio metal to ligand the suggestion structure of   complexes show below   . 
Table (1) physical properties of complexes 
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Results and discussion 
1- Spectroscopy study (FTIR ),UV visible and X-ray 
1.1-FTIR analysis of the complexes 
The relevant band in the (FTIR)of the complexes are listed in Table  (2).In Figure (1)FTIR for ligand show  two 
vibration -OH band for carboxyl group and for phenol group at 3496.94cm-1 and 3338.93cm-1 and for -NH group  
at 3317.66cm-1 .When the two band of  carbonyl group for carboxyl group and amide group recognized at 1771cm-
1 and at 1668.43 as for C=C we show band at 1616.53cm-1. 
In Figure (2) for Cr complex with ligand we show that starching -OH band for carboxyl group at3400.0 
cm-1and starching band for -OH for phenolic group at 3049.4cm-1 but –NH group at 3000cm-1 , and C=O of carbonyl 
group at 1716.65 cm-1 for carboxylic acid ,and at 1688.43cm-1 for amid group as for C=C at 1616.35cm-1 .For N-
Cr group at 661.58cm-1  but for O-Cr at  779.24cm-1. 
In Figure  (3) for Co complex with ligand we show that starching -OH band for carboxyl group at3469.94 
cm-1and starching band for -OH for phenolic group at 3388.93cm-1 but –NH group at 3000cm-1 , and C=O of 
carbonyl group at 1622.13 cm-1 for carboxylic acid ,and at 1553.91cm-1 for amid group as for C=C at 1558.48cm-
1 .For N-Co group at 650cm-1  but for O-Co at  710cm-1. 
In Figure(4)  for Ni complex with ligand we show that starching -OH band for carboxyl group 
at3388.93cm-1and starching band for -OH for phenolic group at 3555.4cm-1 but –NH group at 3300cm-1 , and C=O 
of carbonyl group at 1616.35cm-1 for carboxylic acid ,and at 1558.34cm-1 for amid group as for C=C at 1508.33cm-
1 .For N-Ni group at 600cm-1  but for O-Ni at  750cm-1. 
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Figure (1) FTIR for ligand 
 
 
Figure (2) FTIR for Cr complex with ligand 
Chemistry and Materials Research                                                                                                                                                    www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.8 No.8, 2016 
 
4 
 
Figure (3) FTIR for Co complex with ligand 
 
Figure (4) FTIR for Ni complex with ligand 
 
1.2-UV-Visible spectroscopy  
The solution electronic spectra of the ligand and the complexes were recorded in UV-Visible region . Figure(5) 
shows single band in 308cm-1 of  ligand but shifted of the band to 330cm-1 in Ni-ligand complex  to  π       π* 
tension  that in figure (6). Figure (7) shows four band in( 218,252,280,286)cm-1 for π         π* and n         π* transion 
of Cr-ligand complex ,when in Co-ligand complex we shows tow band in 330and 590 cm-1 for π         π* and 
 n         π* shows in figure (8).    
The powder X-ray diffraction data showed identical features with very poor crystallinty . The patterns of 
the complex had been indexed by standard method s dispersive in intensity for Ni, Cr and  Co  metal complexes.   
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Figure (5) UV-Visible of   ligand 
 
 
Figure (6) UV-Visible of  Ni-ligand complex 
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Figure (7) UV-Visible of  Cr-ligand complex 
 
 
 
 
Figure (8) UV-Visible of  Co-ligand complex 
 
 
 
  
Chemistry and Materials Research                                                                                                                                                    www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.8 No.8, 2016 
 
7 
 
Figure (9) XRD of ligand 
Table (2) powder X-ray diffraction data of the ligand                  
Pos. [°2Th.] Height [cts] FWHM [°2Th.] d-spacing [Å] Rel. Int. [%] 
7.2039 26.81 0.2362 12.27122 13.04 
10.1502 54.94 0.0787 8.71497 26.73 
12.0202 18.56 0.1378 7.36301 9.03 
14.4343 21.02 0.3149 6.13657 10.23 
15.1014 42.80 0.1574 5.86695 20.83 
15.8203 27.10 0.2362 5.60192 13.19 
16.6062 19.75 0.3149 5.33855 9.61 
18.3695 36.39 0.1968 4.82987 17.71 
19.4617 24.77 0.2362 4.56121 12.05 
20.1320 32.64 0.1968 4.41083 15.88 
21.2322 23.97 0.4723 4.18470 11.66 
22.6749 30.83 0.1574 3.92160 15.00 
24.3608 22.13 0.3149 3.65389 10.77 
25.2211 24.24 0.2362 3.53118 11.79 
26.3353 42.76 0.1968 3.38426 20.81 
27.6761 205.52 0.3936 3.22328 100.00 
28.2982 80.43 0.1968 3.15381 39.14 
29.2732 47.97 0.1574 3.05095 23.34 
29.9558 40.01 0.1968 2.98296 19.47 
30.4804 32.83 0.2362 2.93281 15.97 
31.3681 35.18 0.1968 2.85182 17.12 
32.1058 30.47 0.3936 2.78795 14.83 
33.1924 34.49 0.1968 2.69913 16.78 
34.9825 24.57 0.2362 2.56500 11.96 
35.4970 25.00 0.1574 2.52900 12.16 
38.8009 23.88 0.1968 2.32092 11.62 
40.5429 27.56 0.1574 2.22513 13.41 
40.9729 22.74 0.2362 2.20277 11.07 
43.3252 15.44 0.6298 2.08847 7.51 
44.3979 17.53 0.3149 2.04047 8.53 
45.5481 17.28 0.3149 1.99158 8.41 
48.7149 17.14 0.7872 1.86926 8.34 
51.5987 16.38 0.3149 1.77137 7.97 
57.2369 6.60 0.5760 1.60823 3.21 
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Figure (10) Co-ligand complex 
 
Table (3) powder X-ray diffraction data of the ligand-Co complex      
Pos. [°2Th.] Height [cts] FWHM [°2Th.] d-spacing [Å] Rel. Int. [%] 
12.7927 1.38 1.5744 6.92008 2.50 
15.6500 22.07 0.1181 5.66249 40.01 
20.6492 10.32 0.9446 4.30151 18.70 
24.6300 18.37 0.6298 3.61457 33.31 
28.3326 33.80 0.2362 3.15006 61.27 
29.5194 23.58 0.2362 3.02606 42.74 
31.5942 55.16 0.1181 2.83192 100.00 
35.4138 16.12 0.1378 2.53475 29.22 
45.3382 34.37 0.1920 1.99866 62.30 
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Figure (11) Cr-ligand complex  
 
Table (4) powder X-ray diffraction data of the ligand-Cr complex 
Pos. [°2Th.] Height [cts] FWHM [°2Th.] d-spacing [Å] Rel. Int. [%] 
20.6487 2.96 2.5190 4.30161 4.63 
27.6484 20.82 0.5510 3.22644 32.48 
31.7227 64.09 0.0590 2.82073 100.00 
32.7543 1.71 0.2755 2.73422 2.66 
45.5188 33.62 0.1968 1.99279 52.46 
56.5386 13.14 0.1574 1.62777 20.50 
66.2979 3.44 0.2880 1.40870 5.37 
 
 
Chemistry and Materials Research                                                                                                                                                    www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.8 No.8, 2016 
 
10 
 
Figure(12) Ni - ligand complex 
Table (5) powder X-ray diffraction data of the ligand-Ni complex      
Pos. [°2Th.] Height [cts] FWHM [°2Th.] d-spacing [Å] Rel. Int. [%] 
15.9592 48.45 0.0984 5.55349 18.63 
18.5531 43.97 0.1378 4.78248 16.90 
19.1038 18.85 0.1181 4.64584 7.25 
25.2492 17.33 0.2362 3.52731 6.66 
27.9612 17.93 0.2755 3.19105 6.89 
28.5556 16.68 0.2362 3.12597 6.41 
29.9836 18.33 0.2362 2.98027 7.05 
30.6741 35.23 0.1574 2.91473 13.54 
31.8150 41.94 0.1574 2.81277 16.12 
32.7473 19.30 0.2362 2.73479 7.42 
33.4570 26.53 0.1574 2.67838 10.20 
35.2282 260.13 0.0360 2.54556 100.00 
35.3178 126.40 0.0480 2.54562 48.59 
37.4407 19.46 0.1920 2.40006 7.48 
41.5186 15.18 0.2880 2.17327 5.84 
44.7559 10.67 0.2880 2.02330 4.10 
45.6010 25.88 0.3360 1.98775 9.95 
47.9142 7.71 0.9600 1.89704 2.96 
51.6968 5.97 1.1520 1.76678 2.30 
54.1679 7.15 0.5760 1.69187 2.75 
56.5535 7.08 0.5760 1.62603 2.72 
62.1080 2.22 0.6720 1.49328 0.85 
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2-Biological activity 
Number ( ex. three ) extracts,  from   chemical resources were tested,   chemical products used were selected by 
previous antimicrobial activity screening using diffusion method against at least one of the two bacterial strains 
used during the testing. For the diffusion method well-variant, the solvent used was dimethylsulfoxide (DMSO) 
and for the remaining methodologies, suitable solvents were used for the dissolution of the chemical products. 
 
Test-bacteria 
The antibacterial activity of natural products was assessed against two bacteria species: Staphylococcus aurous 
and Escherichia coli . Overnight cultures were used. After 24 h of incubation, bacterial suspension (inoculum) was 
diluted with sterile physiological solution, for the diffusion test, to 108 CFU/ml (turbidity = McFarland barium 
sulfate standard 0.5)13. 
 
Agar diffusion well-variant 
The bacterial inoculums was uniformly spread using sterile cotton swab on a sterile Petri dish MH agar. 50 µl from 
1mg/ml concentration of chemical products were added to each well (7 mm diameter holes cut in the agar gel, 20 
mm apart from one another). The plates were incubated for 24 h at 36ºC ± 1ºC, under aerobic conditions. After 
incubation, confluent bacterial growth was observed. Inhibition of the bacterial growth was measured in mm13. 
Antimicrobial activity 
Name of compound Concentration Inhibition diameters  mm 
Staphylococcus aurous Escherichia coli 
              Ligand   100 ppm 18 20 
Ni-ligand complex 100 ppm Zero 11 
Co-ligand complex 100 ppm Zero Zero 
Cr-ligand complex 100 ppm 15 Zero 
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